INTENSIVE CARE
8dI2AMDUa
8dI2AMDUa
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
healthy, nonpregnant women, in whom these cutoffs would still<br />
be considered within the normal reference range.<br />
Untreated Depression and Pregnancy<br />
Untreated depression during pregnancy is associated with an<br />
increased risk for preterm birth and low birth weight — two<br />
of the leading causes of mortality and morbidity in infants —<br />
results of a new meta-analysis suggest. “Although this does<br />
not mean that treating depression with antidepressants will<br />
reduce these risks, this is an important piece of information<br />
for clinicians and women to take into account in the decisionmaking<br />
process around management of depression,” said lead<br />
author Alexander Jarde, PhD, postdoctoral fellow, Department<br />
of Obstetrics and Gynecology, McMaster University, Hamilton,<br />
Ontario, Canada. The analysis showed that the odds of preterm<br />
birth reported in studies by authors receiving support from<br />
pharmaceutical companies were significantly higher than<br />
the odds reported in studies by authors who did not receive<br />
such support. Researchers performed an exhaustive literature<br />
search for randomized and nonrandomized studies reporting<br />
adverse neonatal outcomes in pregnant women with untreated<br />
depression in comparison with pregnant women without<br />
depression. Studies assessed depression using either a clinical<br />
interview/diagnosis or a screening tool or scale.<br />
NANN PREVIEW<br />
Accriva Diagnostics<br />
Booth 112<br />
What products do you plan to exhibit at NANN?<br />
Accriva Diagnostics will be featuring our Tenderfoot line of<br />
infant heel incision devices ranging from Micro-Preemie to<br />
Toddler sizes. For over 25 years, the Tenderfoot has been the<br />
gold standard in the industry and is the only heel incision device<br />
made in America. We take pride in our quality systems that are<br />
overseen by a team of highly skilled engineers to ensure that we<br />
provide a premium product.<br />
What’s new this year? Tell us about your latest products<br />
or future plans.<br />
None compare to the Tenderfoot’s patented Softsweep <br />
technology. As the originator of heel incision devices, many<br />
have tried to replicate our proprietary technology, but cannot<br />
achieve the same results. When used as intended, the Tenderfoot<br />
produces a consistent incision arc that is controlled to a depth<br />
just above the nerve fibers. This benefits a device that is safe,<br />
easy to use, and virtually pain free with less bruising when<br />
compared with traditional lancet devices.<br />
Why should our readers stop by your display?<br />
At this year’s NANN we will be introducing the Tenderfoot<br />
Educational Kit that can be ordered to help train and educate<br />
your neonatal nursing team. Kits can be ordered by visiting<br />
www.TenderfootCares.com or by stopping by our NANN booth.<br />
The Tenderfoot Educational Kits will include:<br />
• Sample devices for hands-on training<br />
• Newborn-sized foam foot<br />
• Instructional video<br />
• White paper on proper newborn blood collection<br />
Accriva Diagnostics manufactures a range of products to<br />
help support our Neonatal Caregivers. Visit us to learn about<br />
our Hemochron line of products for ECMO centers, and our<br />
Avoximeter 4000 instrument for monitoring MetHb in infants.<br />
CODAN<br />
Booth 220<br />
What products do you plan to exhibit at NANN?<br />
CODAN, a leading medical device manufacturer of high<br />
quality IV delivery systems, will feature Closed Medication<br />
Administration Sets specifically designed for the NICU and PICU<br />
at NANN. The sets focus on infection prevention and offer an<br />
alternative to standard open medication delivery systems that<br />
present a serious health concern and contribute to increased<br />
infection rates.<br />
All-in-one CODAN neonate/pediatric sets eliminate the need<br />
to assemble multiple sets, increase efficiencies of line change<br />
outs and decrease CLABSI rates. Made in the USA product line<br />
includes completely sterile burettes for truly sterile procedures.<br />
• Preassembled Systems Save Precious Setup Time<br />
• 0.2 and 1.2 Micron Air Eliminating Filters<br />
• Needlefree Adapters<br />
• MiniBore and MicroBore Tubing for Low Priming Volume<br />
• Available for Use with Any Syringe Pump<br />
• Color-Coded Clamps for Verification of Medication Use<br />
• Bifurcated, Trifurcated and Quad Furcated Sets<br />
• Reduced Material Management Cost<br />
• Back Check Valves Prevent “Free Flow”<br />
• TPN and Custom Sets<br />
• Non-DEHP and Latex Free<br />
Why should our readers stop by your display?<br />
CODAN is an environmentally conscious manufacturer of clean,<br />
safe and simple specialty products for the Infusion Therapy<br />
Market. CODAN Label product lines include high quality IV sets<br />
and components for neonatal, pediatric, pharmacy, anesthesia,<br />
oncology and cytotoxic drug delivery. Through decades of<br />
experience and working closely with clinical practitioners,<br />
CODAN is committed to innovative applications and new<br />
product development. Our manufacturing schedule is flexible<br />
and we respond quickly to client needs. Custom sets are<br />
available in 4 weeks. For further information, call (800) 332-6326<br />
or visit www.codanuscorp.com.<br />
Draeger<br />
Booth 404<br />
What products do you plan to exhibit at NANN?<br />
Jaundice management, incubators.<br />
What’s new this year? Tell us about your latest products<br />
or future plans.<br />
Dräger will redefine neonatal care with the launch of its new<br />
technology for optimal thermoregulation and developmental care<br />
for neonates.<br />
Why should our readers stop by your display?<br />
Visitors will be able to experience hands on the latest<br />
innovation in thermoregulation technology in more than 10<br />
years.<br />
14 neonatal <strong>INTENSIVE</strong> <strong>CARE</strong> Vol. 29 No. 4 • Fall 2016